Centese Funding & Investors
Centese is a medical device company that develops Thoraguard, a reliable surgical drainage system. Using digital intelligence, Thoraguard revolutionizes operative drainage in cardiothoracic surgery. Thoraguard is a digital technology that provides accurate data monitoring and automatic chest tube clearing with the goal of enhancing clinical judgment and patient safety. Centese is committed to delivering improved post-operative surgical drainage solutions that are designed for safety, intelligence, and effectiveness in order to enhance results and save costs in cardiothoracic surgery.
centese.comTotal Amount Raised: $18,589,998
Centese Funding Rounds
Series B
$15,000,000
Series B Investors
MedTech Venture PartnersSeries A
$2,000,000
Series A Investors
Invest NebraskaGrant
$1,409,999
Grant Investors
National Science Foundation (NSF)Grant
$179,999
Grant Investors
National Science Foundation (NSF)
Funding info provided by Diffbot.